Announcements Trials
Browse Landscape

Phase

Phase 2 27Phase 1 9Phase 1/2 3Phase NA 1Phase 2/3 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 11Breast Neoplasms 10Stomach Neoplasms 8Prostatic Neoplasms 7Squamous Cell Carcinoma of Head and Neck 4Lung Neoplasms 4Gastrointestinal Neoplasms 3Neoplasms 2Head and Neck Neoplasms 2HER2-positive Breast Cancer 2Uterine Cervical Neoplasms 1Triple Negative Breast Neoplasms 1Stage I Prostate Adenocarcinoma AJCC v7 1Squamous Cell Non-small Cell Lung Cancer 1Recurrent Squamous Cell Lung Carcinoma 1Recurrence 1Progression Free Survival 1Pathologic Complete Response 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Pancreatic Neoplasms 1Oropharyngeal Neoplasms 1Neoplasm Recurrence, Local 1Neoplasm Metastasis 1Nasopharyngeal Carcinoma 1Mouth Neoplasms 1Lymphoid Interstitial Pneumonia 1Laryngeal Neoplasms 1Hypopharyngeal Neoplasms 1HER2-negative Breast Cancer 1FGFR1 Gene Amplification 1

Interventions

Gemcitabine 16Fluorouracil 6Irinotecan 4Cisplatin 4Capecitabine 4Oxaliplatin 3Albumin-Bound Paclitaxel 3130-nm albumin-bound paclitaxel 3nimotuzumab 2Taxes 2Phytotherapy 2Leucovorin 2Drug Therapy 2surufatinib 1rubitecan 1racemetyrosine 1pertuzumab 1pembrolizumab 1methylnaltrexone 1folfirinox 1cyclopropapyrroloindole 1camrelizumab 1Trastuzumab 1Tranexamic Acid 1Standard of Care 1Sirolimus 1Radiotherapy 1Positron Emission Tomography Computed Tomography 1Phenytoin 1Paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2/3 × Pancreatic Neoplasms × Docetaxel × Clear all
NCT01065870 2014-01-29

Neoadjuvant GTX With Chemoradiation for Pancreatic Cancer (Stage II/III)

Columbia University

Phase 2/3 Unknown
64 enrolled
Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡